DKK2 and neoplasm: Our results for patients after a primary resection are consistent with previous studies for gastric, colon, breast and hepatocellular carcinoma, where DKK2 was found as a tumor suppressor and its loss is associated with activation of the Wnt-pathway and consecutive tumor progression [19,20,21,22,23,24].